PMA

P050006: GORE HELEX SEPTAL OCCLUDER

FDA PMA · Transcatheter septal occluder · W. L. Gore & Associates, Inc.

Key facts

PMA number P050006
Trade name GORE HELEX SEPTAL OCCLUDER
Generic name Transcatheter septal occluder
Applicant W. L. Gore & Associates, Inc.
Owner/operator W. L. GORE & ASSOCIATES, INC.
Product code MLV
Approval date Aug 11, 2006
Docket number 06M-0341
Notice date Aug 25, 2006
Establishment registration 2017233
FEI number 2017233

At a glance

  • 100–999 Supplements
  • Aug 3, 2026 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • 10–99 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals